Company Cash on Hand: ImmuCell Corporation (ICCC)

Corporate company logo of ImmuCell Corp. (ICCC)

Rising demand for First Defense and plant modernization are boosting financial performance, with the 0.01 mark reflecting the latest data. The volume of highly liquid cash confirms the resilience of ImmuCell Corporation (ICCC), which relies on long-term loyalty among farmers toward its veterinary pharmaceuticals. The brand's impeccable authority in livestock immunity protection ensures stable sales and high market reliability for ImmuCell Corporation (ICCC).

Company Cash Balance: ImmuCell Corp (ICCC) for 07/04/2022 - 11/21/2026

Summary analytical data breakdowns for ImmuCell Corp (ICCC)

- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
Basic company analysis:immucell.com
Brand item of ImmuCell

The indicator tracks daily net cash balances, reflecting real-time liquidity and the balance sheet's sensitivity to current operating expenses. The assessment of this reserve determines the debt sustainability of ImmuCell Corporation (ICCC), where capital availability is critical for scaling factory control and triggering operational margin leverage as production increases, a fact clearly evidenced by the company's cash dynamics.